SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-19-000474
Filing Date
2019-11-19
Accepted
2019-11-19 15:35:36
Documents
44
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING SEPT 30, 2019 bivi-20190930_10q.htm 10-Q 322095
2 EXHIBIT 31.1 bivi-20190930_10qex31z1.htm EX-31.1 11853
3 EXHIBIT 31.2 bivi-20190930_10qex31z2.htm EX-31.2 11976
4 EXHIBIT 32.1 bivi-20190930_10qex32z1.htm EX-32.1 5017
5 EXHIBIT 32.2 bivi-20190930_10qex32z2.htm EX-32.2 4860
  Complete submission text file 0001520138-19-000474.txt   1900680

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bivi-20190930.xml EX-101.INS 283484
7 XBRL CALCULATION FILE bivi-20190930_cal.xml EX-101.CAL 31116
8 XBRL DEFINITION FILE bivi-20190930_def.xml EX-101.DEF 75192
9 XBRL LABEL FILE bivi-20190930_lab.xml EX-101.LAB 194622
10 XBRL PRESENTATION FILE bivi-20190930_pre.xml EX-101.PRE 143382
11 XBRL SCHEMA FILE bivi-20190930.xsd EX-101.SCH 25652
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 191231015
SIC: 2834 Pharmaceutical Preparations